The relationship between hemodialysis mortality and the Chinese medical insurance type
Author:
Affiliation:
1. Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China;
2. Key Laboratory of Kidney Disease Prevention and Control Technology, Hangzhou, Zhejiang, China
Publisher
Informa UK Limited
Subject
Nephrology,Critical Care and Intensive Care Medicine,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/0886022X.2019.1657893
Reference36 articles.
1. Latent learning in End Stage Renal Disease (ESRD)
2. Prevalence of chronic kidney disease in China: a cross-sectional survey
3. Nephrology in China
4. Prevalence of chronic kidney disease and its association with metabolic diseases: a cross-sectional survey in Zhejiang province, Eastern China
5. The global burden of reduced GFR: ESRD, CVD and mortality
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Health insurance provider and endovascular treatment availability are associated with different hemodialysis vascular access profiles: A Brazilian national survey;Frontiers in Nephrology;2022-12-07
2. Effects of dialysis modality on mortality in patients with end‐stage renal disease: A cohort study;Seminars in Dialysis;2022-07-13
3. Seasonal Variation: A Non-negligible Factor Associated With Blood Pressure in Patients Undergoing Hemodialysis;Frontiers in Cardiovascular Medicine;2022-03-18
4. The role of sustainable urban employee basic medical insurance in health risk appraisal of urban residents;Work;2021-07-17
5. Tackling Dialysis Burden around the World: A Global Challenge;Kidney Diseases;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3